Clinical Trials Logo

Difference of 12-hour AUC clinical trials

View clinical trials related to Difference of 12-hour AUC.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01780948 Completed - Clinical trials for Difference of 12-hour AUC

Pharmacokinetic of Everolimus and Atorvastatin Co-administration

Start date: September 2012
Phase: N/A
Study type: Interventional

Hypothesis : In renal transplantation recipient who received immunosuppressive drug "certican" and have hypercholesterolemia will get lipid lower drug-HMG Co-A reductase inhibitors. Because atorvastatin and everolimus have metabolism via Cytochrome P450 subfamily 3A4 both, so investigator made the hypothesis that when patients received everolimus with atorvastatin will change area under the time concentration curve of everolimus.